• Science and Research

  Alaxia Partners with iABC to Speed Development of ALX-009

  Posted by Cystic Fibrosis News Moderator on November 8, 2019 at 11:27 am

  

  Alaxia has joined the European consortium iABC to speed development of ALX-009, an inhaled antibiotic for drug resistant lung infections in CF patients. Click here to read more from it.

  What do you think of this news?

  Cystic Fibrosis News Moderator replied 6 years, 4 months ago 1 Member · 0 Replies
• 0 Replies

Log In to Reply